ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,979.39
      -0.63%
      US Tech 100
      16,685.20
      -1.48%
      Dow Jones
      37,969.05
      0.51%
      Brent Oil
      86.845
      0.50%
      Bitcoin
      64,512.93
      1.58%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sutro Biopharma Inc (STRO)

      7. Sutro Biopharma Inc (STRO) News

      STRO Sutro Biopharma Inc

      3.615
      -0.155 (-4.11%)
      Last Updated: 13:45:09
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Sutro Biopharma Inc STRO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.155 -4.11% 3.615 13:45:09
      Open Price Low Price High Price Close Price Prev Close
      3.75 3.60 3.80 3.77
      more quote information »

      Recent News

      Date Time Source Heading
      4/02/202406:18GLOBESutro Biopharma Announces Pricing of $75 Million..
      3/25/202416:30GLOBESutro Biopharma Reports Full Year 2023 Financial Results,..
      3/07/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/27/202416:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/13/202412:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/12/202406:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/09/202416:27EDGAR2Form 8-K - Current report
      2/09/202416:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      2/06/202416:05GLOBESutro Biopharma to Participate in Upcoming Investor..
      1/31/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/29/202417:14EDGAR2Form 144 - Report of proposed sale of securities
      1/08/202407:31EDGAR2Form 8-K - Current report
      1/04/202416:05GLOBESutro Biopharma Highlights Potential Multi-Cancer..
      12/14/202316:05GLOBESutro Biopharma to Host Investor Webcast Highlighting..
      12/11/202316:05GLOBESutro Biopharma Announces New Positive Data from the..
      12/04/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/04/202316:05GLOBESutro Biopharma to Participate in the JMP Securities..
      11/27/202316:05EDGAR2Form 8-K - Current report
      11/27/202316:00GLOBEVaxcyte Exercises Option and Enters into Manufacturing..
      11/22/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      11/21/202316:05EDGAR2Form 8-K - Current report
      11/21/202316:05GLOBESutro Biopharma Promotes Jane Chung to President and Chief..
      11/13/202317:18EDGAR2Form S-3 - Registration statement under Securities Act of..
      11/13/202316:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202316:30EDGAR2Form 8-K - Current report
      11/13/202316:30GLOBESutro Biopharma Reports Third Quarter 2023 Financial..
      10/22/202304:25GLOBESutro Biopharma Announces Presentation of Data for..
      10/16/202316:05GLOBESutro Demonstrates Meaningful ADC Innovation with Five..
      10/04/202316:31EDGAR2Form 8-K - Current report
      9/19/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/19/202316:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
      9/19/202308:00GLOBESutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief..
      8/30/202308:00GLOBESutro Biopharma to Participate in Upcoming Investor..
      8/29/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/28/202316:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/25/202316:46EDGAR2Form 144 - Report of proposed sale of securities
      8/11/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/10/202316:31EDGAR2Form 8-K - Current report
      8/10/202316:30GLOBESutro Biopharma Reports Second Quarter 2023 Financial..
      7/13/202318:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      6/26/202308:00GLOBESutro Biopharma and Blackstone Announce Royalty Financing..
      6/03/202316:00GLOBESutro Biopharma Announces Oral Presentation at ASCO 2023..
      5/31/202308:00GLOBESutro Biopharma to Participate in the Jefferies Healthcare..
      5/15/202308:00GLOBESutro Biopharma Reports First Quarter 2023 Financial..

      Your Recent History

      NASDAQ
      STRO
      Sutro Biopharma
      Delayed Upgrade Clock